Celularity (CELUW) Change in Receivables (2020 - 2025)
Celularity (CELUW) reported Change in Receivables of -$548000.0 for Q4 2025, down 110.91% year-over-year from $5.0 million in Q4 2024, and up 87.94% quarter-over-quarter from -$4.5 million in Q3 2025.
Celularity (CELUW) Change in Receivables (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Change in Receivables data on file, last reported at -$548000.0 in Q4 2025.
- Change in Receivables for Q4 2025 came in at -$548000.0, down 110.91% year-over-year; the trailing twelve-month figure through Dec 2025 was -$7.6 million (down 290.3% YoY), and the FY2025 annual result was -$7.6 million, down 290.3% from the prior year.
- Change in Receivables advanced to -$548000.0 in Q4 2025 per CELUW's latest filing, from -$4.5 million in the prior quarter.
- Over five years, Change in Receivables peaked at $6.7 million in Q4 2023 and troughed at -$4.8 million in Q3 2024.
- A 5-year average of $436850.0 and a median of $469500.0 in 2021 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2021 and 2025: Change in Receivables surged 717.65% in 2021, then tumbled 1883.33% in 2025.
- A 5-year view of Change in Receivables shows it stood at $1.2 million in 2021, then decreased by 22.42% to $896000.0 in 2022, then jumped by 648.77% to $6.7 million in 2023, then decreased by 25.15% to $5.0 million in 2024, then plunged by 110.91% to -$548000.0 in 2025.
- Business Quant data shows CELUW's Change in Receivables at -$548000.0 in Q4 2025, -$4.5 million in Q3 2025, and -$3.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Celularity | - | - | -3.27 Mn | -548,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -548,000.00 |
| Dec 31, 2025 | -548,000.00 |
| Sep 30, 2025 | -4.55 Mn |
| Sep 30, 2025 | -4.55 Mn |
| Jun 30, 2025 | -3.81 Mn |
| Jun 30, 2025 | -3.81 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | -4.79 Mn |
| Sep 30, 2024 | -4.79 Mn |
| Jun 30, 2024 | -192,000.00 |
| Jun 30, 2024 | -192,000.00 |
| Mar 31, 2024 | 3.92 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Sep 30, 2023 | 1.38 Mn |